Molecular Mechanisms of Drug Repurposing for Neuropsychiatric Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 15 October 2024 | Viewed by 24
Special Issue Editors
Interests: inflammation; anti-inflammatory drugs; depression; antidepressant drugs; biomarkers; drug delivery systems; in vivo animal models
Special Issues, Collections and Topics in MDPI journals
Interests: polymers; biocompatible; biodegradable; bioconjugates; nanoparticles; microparticles; drug delivery systems; biological targets; animal models
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are delighted to announce a Special Issue which aims to spotlight the promising approach of utilizing existing medications to address various neuropsychiatric conditions, thereby fostering innovative therapeutic strategies and advancements in patient care.
In recent years, drug repurposing has emerged as a compelling strategy in neuropsychiatric research, offering the potential to expedite the development of new treatments by leveraging established pharmacological agents with well-known safety profiles. This approach not only provides opportunities for cost-effective drug development but also holds the promise of addressing unmet medical needs and enhancing patient outcomes.
We cordially invite researchers, and experts in the field to contribute original research articles, reviews, case studies, and perspectives that delve into the multifaceted aspects of drug repurposing in neuropsychiatric disorders. Since IJMS is a journal of molecular science, purely clinical studies will not be suitable. However, clinical or pure model submissions with biomolecular experiments are welcomed.
We eagerly anticipate your valuable contributions to this Special Issue.
Dr. Maria Bogdan
Prof. Dr. Liliana Mititelu-Tartau
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- animal models
- neurodegeneration
- neuropsychiatric disorders
- neuroprotection
- nanoparticles
